Company to be Featured in Upcoming High-Profile Media
Vancouver, British Columbia, Canada, April 8, 2021 – Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, has initiated a comprehensive marketing initiative designed to greatly amplify the message and mission of the organization to its key audiences – medical cannabis growers, consumers, resellers, and investors.
The Company is executing its marketing plan to bring its Citizen Green cannabis compliance technologies to more cannabis cultivators and to increase investor awareness in U.S. Canada and Europe. Building-on its recent capital markets success in attracting CDN$3million of new investment, GCAC’s latest investor outreach initiatives also seek to expand its investor base in China.
This multi-channel communications strategy involves marketing, promotion, thought leadership development, and strategic social media activation of several upcoming high-profile opportunities:
- Securing a dedicated public relations agency to facilitate outreach and earned media interviews and placements
- Engaging through ongoing television, radio, and podcast interviews featuring GCAC CEO Brad Moore, which includes Fox News, Bloomberg, New to the Street and more
- Speaking engagements at high-profile events also featuring Brad Moore, expanding the reach and engagement of GCAC to a global level
Upcoming events include:
- 4/14: WallStreet Research Virtual Webinar and Q&A Series
Register to attend here
- 4/15: Global Chinese Financial Forum (GCFF) Virtual Conference 2021
Register to attend here
- 6/22-23: Cannabis Business Europe 2021, Frankfurt, Germany
Book Tickets here
Brad Moore, Chief Executive Officer of GCAC, had this to say regarding the performance of the campaign, “The response thus far among investors, growers, and consumers alike has been phenomenal. By consistently telling our story GCAC continues to see balanced, incremental growth in our market value since September 2020. We are happy for our investors who have loyally hung in there but also because most of primary customers are publicly traded companies. With growth as high as 1933% it’s hard for us not to get noticed, which leads to having conversations on how we can move towards better outcomes for medical cannabis patients”.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world’s first end-to-end – from patient to regulator – medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high quality cannabis datasets that improve patient outcomes and to become the world’s largest cannabis efficacy data provider.
Phone: +1 (800) 409-5679
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.